NF
VRTX icon

Nvest Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Nvest Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247K Hold
554
– – 0.09% 129
2025
Q4 		$251K Buy
554
+5
+0.9% +$2.15K 0.1% 119
2025
Q3 		$215K Buy
549
+36
+7% +$15K 0.12% 119
2025
Q2 		$228K Buy
513
+14
+3% +$6.45K 0.12% 99
2025
Q1 		$242K Hold
499
– – 0.13% 91
2024
Q4 		$201K Hold
499
– – 0.1% 109
2024
Q3 		$232K Hold
499
– – 0.13% 87
2024
Q2 		$234K Sell
499
-3
-0.6% -$1.3K 0.14% 83
2024
Q1 		$210K Sell
502
-6
-1% -$2.54K 0.14% 77
2023
Q4 		$207K Buy
+508
New +$188K 0.16% 67

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nvest Financial's VRTX Position: Q1 2026 in Review

Nvest Financial held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 554 shares worth $247K. The position accounts for 0.09% of the portfolio, ranked #129.

Nvest Financial first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $251K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Nvest Financial held 554 shares of Vertex Pharmaceuticals worth $247K as of Q1 2026.
  • Nvest Financial left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.09% of Nvest Financial's portfolio in Q1 2026, its #129 holding.
  • Nvest Financial first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Nvest Financial's Vertex Pharmaceuticals position peaked at $251K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Nvest Financial's 13F filing for Q1 2026, filed 28 Apr 2026.